Neuroprosthetic breakthroughs in AMD treatment: Who benefits, who’s left behind, and the ethics of restoring vision as a marketable commodity
Original framing: “This implant can restore sight for patients with macular degeneration” — MIT Technology Review
Indigenous knowledge systems offer preventative and adaptive frameworks for AMD that challenge the implant’s reactive, tech-dependent model. For example, the *Navajo* practice of consuming *chokecherry* (high in antioxidants) and avoiding processed foods aligns with modern nutritional science but is erased by narratives that position implants as the sole 'innovation.' Similarly, the *Maori* concept of *whakapapa* (genealogical connection to land) links eye health to ecological balance—something the Prima system ignores by treating vision as an isolated biological function. The absence of these perspectives reinforces colonial erasure, where Indigenous solutions are either co-opted (e.g., patented herbs) or dismissed as 'alternative,' while high-tech fixes are framed as universally applicable. This omission is critical, as Indigenous communities often bear the highest AMD burdens due to displacement from traditional lands and diets, yet their adaptive strategies are treated as irrelevant to 'modern' medicine.
The Prima retinal implant is not a neutral technological breakthrough but a symptom of a healthcare system that externalizes costs, medicalizes aging, and prioritizes corporate profit over equity.
Its narrative obscures a web of power structures: biotech patents that extend control over bodily autonomy, historical eugenicist legacies that pathologize disability, and environmental injustices that make AMD a preventable crisis for the poor. Cross-cultural evidence—from *Maori rongoā* to *Japanese* forest bathing—demonstrates that vision health is not a solitary medical problem but a systemic one, tied to land stewardship, food sovereignty, and community care. The implant’s rollout risks deepening inequities by treating AMD as an individual tragedy rather than a collective failure, while its $100K price tag reveals how 'innovation' is often a euphemism for exclusion. To move forward, solutions must center *prevention* (e.g., agrochemical bans), *decolonized care* (e.g., Indigenous-public health hybrids), and *disability-led tech* (e.g., open-source prosthetics)—not just the next generation of implants. The trickster’s lesson here is clear: what appears as a 'restorative' miracle is often a distraction from the real work of justice.